Human inhibitor antibodies specific for the factor VIII A2 domain disrupt the interaction between the subunit and factor IXa.
Factor VIIIa, a heterotrimer of the A1, A2, and A3-C1-C2 subunits, increases the catalytic efficiency for factor IXa-catalyzed activation of factor X. A significant fraction of naturally occurring, anti-factor VIII inhibitor antibodies reacts with the A2 domain. Utilizing the capacity for isolated A2 subunit to stimulate factor IXa activity, we show that a panel of these inhibitors block this activity. Inhibition of activity parallels the antibody potency as measured in the Bethesda assay. These antibodies also block the A2-dependent increases in fluorescence anisotropy of fluorescein-Phe-Phe-Arg factor IXa. Similar to the IgG fractions, a peptide representing the sequence of the inhibitor epitope (A2 residues 484-509) blocked the A2-dependent stimulation of factor IXa. These results indicate that antibodies possessing this specificity directly inhibit the interaction of A2 subunit with factor IXa, thus abrogating the contribution of this subunit to cofactor activity. Furthermore, these results also suggest that factor VIII residues 484-509 contribute to a factor IXa-interactive site.
Fay
P J
PJ
Department of Biochemistry, University of Rochester School of Medicine, Rochester, New York 14642, USA. Philip_Fay@urmc.rochester.edu
Scandella
D
D
D000911:Antibodies, Monoclonal / Q000276:immunology*; D000918:Antibody Specificity; D015949:Factor IXa / Q000276:immunology*; D005169:Factor VIII / Q000737:chemistry / Q000276:immunology*; D005454:Fluorescence Polarization; D006801:Humans; D011994:Recombinant Proteins / Q000737:chemistry / Q000276:immunology
D000911:Antibodies, Monoclonal; D011994:Recombinant Proteins; D005169:Factor VIII; D015949:Factor IXa